down arrow

Alembic

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE426A01027
  • NSEID: ALEMBICLTD
  • BSEID: 506235
INR
97.61
1.29 (1.34%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.92 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

97.0199.49

52 Week

85.55169.00
Valuation
Technical
Day's Volume

CASH

2.92 lacs (-81.40%) Volume

Shareholding (Dec 2024)

FII

1.78%

Held by 53 FIIs

DII

0.06%

Held by 0 DIIs

Promoter

70.88%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Stock is technically in a Bearish range

  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
2

With ROE of 13.8, it has a Very Expensive valuation with a 1.1 Price to Book Value

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 2,506 Cr (Small Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

2.59%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

13.82%

stock-summary
Price to Book

1.10

Revenue and Profits (1 Year):
Net Sales:
58 Cr
(Quarterly Results - Dec 2024)
Net Profit:
65 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.59%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-29.63%
0%
-29.63%
1 Year
1.56%
2.59%
4.15%
2 Years
59.23%
7.11%
66.34%
3 Years
12.71%
9.62%
22.33%
4 Years
-7.74%
5.43%
-2.31%
5 Years
114.76%
13.91%
128.67%

Latest dividend: 2.4 per share ex-dividend date: Aug-05-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.14%
EBIT Growth (5y)
80.47%
EBIT to Interest (avg)
21.84
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.05
Tax Ratio
7.01%
Dividend Payout Ratio
22.94%
Pledged Shares
0
Institutional Holding
1.85%
ROCE (avg)
1.03%
ROE (avg)
12.72%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
33
Price to Book Value
1.10
EV to EBIT
30.14
EV to EBITDA
27.03
EV to Capital Employed
1.10
EV to Sales
11.62
PEG Ratio
0.34
Dividend Yield
2.59%
ROCE (Latest)
2.99%
ROE (Latest)
13.82%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 53 FIIs (1.78%)

Promoter with highest holding

Nirayu Limited (63.06%)

Highest Public shareholder

None

Individual Investors Holdings

21.76%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 47.30% vs 28.45% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 6.50% vs 34.59% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "57.92",
          "val2": "39.32",
          "chgp": "47.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.40",
          "val2": "11.67",
          "chgp": "126.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.69",
          "val2": "0.37",
          "chgp": "86.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "65.39",
          "val2": "61.40",
          "chgp": "6.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "45.58%",
          "val2": "29.68%",
          "chgp": "15.90%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 50.03% vs 16.13% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 30.93% vs 39.55% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "103.70",
          "val2": "69.12",
          "chgp": "50.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "39.98",
          "val2": "21.03",
          "chgp": "90.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.16",
          "val2": "0.26",
          "chgp": "346.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "176.84",
          "val2": "135.06",
          "chgp": "30.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.55%",
          "val2": "30.43%",
          "chgp": "8.12%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 49.04% vs 20.32% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 23.30% vs 37.96% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "161.62",
          "val2": "108.44",
          "chgp": "49.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "66.38",
          "val2": "32.70",
          "chgp": "103.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.85",
          "val2": "0.63",
          "chgp": "193.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "242.23",
          "val2": "196.46",
          "chgp": "23.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "41.07%",
          "val2": "30.15%",
          "chgp": "10.92%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 23.77% vs 62.67% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 40.90% vs -14.14% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "157.49",
          "val2": "127.24",
          "chgp": "23.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "56.86",
          "val2": "40.34",
          "chgp": "40.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.11",
          "val2": "0.47",
          "chgp": "136.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-10.61",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "268.62",
          "val2": "190.65",
          "chgp": "40.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.10%",
          "val2": "31.70%",
          "chgp": "4.40%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
57.92
39.32
47.30%
Operating Profit (PBDIT) excl Other Income
26.40
11.67
126.22%
Interest
0.69
0.37
86.49%
Exceptional Items
0.00
0.00
Consolidate Net Profit
65.39
61.40
6.50%
Operating Profit Margin (Excl OI)
45.58%
29.68%
15.90%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 47.30% vs 28.45% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 6.50% vs 34.59% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
103.70
69.12
50.03%
Operating Profit (PBDIT) excl Other Income
39.98
21.03
90.11%
Interest
1.16
0.26
346.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
176.84
135.06
30.93%
Operating Profit Margin (Excl OI)
38.55%
30.43%
8.12%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 50.03% vs 16.13% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 30.93% vs 39.55% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
161.62
108.44
49.04%
Operating Profit (PBDIT) excl Other Income
66.38
32.70
103.00%
Interest
1.85
0.63
193.65%
Exceptional Items
0.00
0.00
Consolidate Net Profit
242.23
196.46
23.30%
Operating Profit Margin (Excl OI)
41.07%
30.15%
10.92%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 49.04% vs 20.32% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 23.30% vs 37.96% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
157.49
127.24
23.77%
Operating Profit (PBDIT) excl Other Income
56.86
40.34
40.95%
Interest
1.11
0.47
136.17%
Exceptional Items
0.00
-10.61
100.00%
Consolidate Net Profit
268.62
190.65
40.90%
Operating Profit Margin (Excl OI)
36.10%
31.70%
4.40%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 23.77% vs 62.67% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 40.90% vs -14.14% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Alembic Ltd stock-summary
stock-summary
Alembic Ltd
Small Cap
Pharmaceuticals & Drugs
Alembic Limited is one of the India's most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in three lines of business, manufacture of Bulk Drugs, Real Estate and Power Generation through Windmills and Co-gen Power Plant which is presently used for captive consumption for the operation of the Bulk Drugs Manufacturing plant at Vadodara.
Company Coordinates stock-summary
Company Details
Alembic Road , Vadodara Gujarat : 390003
stock-summary
Tel: 91-0265-2280550
stock-summary
http://www.alembiclimited.com
stock-summary
alembic.investors@alembic.co.in
Registrar Details
Link Intime India Pvt Ltd., B-102 & B103, Shangrila Complex, First Floor, Opp: HDFC Bank, Near Radhakrishna Char Rasta, Akota, Vadodara
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."